CA2433962C - Compositions antibacteriennes de clarithromycine et processus de preparation connexe - Google Patents

Compositions antibacteriennes de clarithromycine et processus de preparation connexe Download PDF

Info

Publication number
CA2433962C
CA2433962C CA2433962A CA2433962A CA2433962C CA 2433962 C CA2433962 C CA 2433962C CA 2433962 A CA2433962 A CA 2433962A CA 2433962 A CA2433962 A CA 2433962A CA 2433962 C CA2433962 C CA 2433962C
Authority
CA
Canada
Prior art keywords
clarithromycin
abridged
granular
extra
granular excipient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA2433962A
Other languages
English (en)
Other versions
CA2433962A1 (fr
Inventor
Azita Saleki-Gerhardt
Rick Rafeldt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BGP Products Operations GmbH
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4171189&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2433962(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Priority to CA2433962A priority Critical patent/CA2433962C/fr
Publication of CA2433962A1 publication Critical patent/CA2433962A1/fr
Application granted granted Critical
Publication of CA2433962C publication Critical patent/CA2433962C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La composition antibactérienne abrégée de la clarithromycine et les méthodes de préparation sont décrites.
CA2433962A 2002-07-19 2002-07-19 Compositions antibacteriennes de clarithromycine et processus de preparation connexe Expired - Lifetime CA2433962C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA2433962A CA2433962C (fr) 2002-07-19 2002-07-19 Compositions antibacteriennes de clarithromycine et processus de preparation connexe

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002393614A CA2393614C (fr) 2002-07-19 2002-07-19 Compositions antibacteriennes de clarithromycine et processus de preparation connexe
CA2433962A CA2433962C (fr) 2002-07-19 2002-07-19 Compositions antibacteriennes de clarithromycine et processus de preparation connexe

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002393614A Division CA2393614C (fr) 2002-07-19 2002-07-19 Compositions antibacteriennes de clarithromycine et processus de preparation connexe

Publications (2)

Publication Number Publication Date
CA2433962A1 CA2433962A1 (fr) 2002-10-28
CA2433962C true CA2433962C (fr) 2012-10-30

Family

ID=4171189

Family Applications (2)

Application Number Title Priority Date Filing Date
CA002393614A Expired - Lifetime CA2393614C (fr) 2002-07-19 2002-07-19 Compositions antibacteriennes de clarithromycine et processus de preparation connexe
CA2433962A Expired - Lifetime CA2433962C (fr) 2002-07-19 2002-07-19 Compositions antibacteriennes de clarithromycine et processus de preparation connexe

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CA002393614A Expired - Lifetime CA2393614C (fr) 2002-07-19 2002-07-19 Compositions antibacteriennes de clarithromycine et processus de preparation connexe

Country Status (1)

Country Link
CA (2) CA2393614C (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004006917A1 (fr) * 2002-07-16 2004-01-22 Ranbaxy Laboratories Limited Comprimes dispersibles pour administration par voie orale
RU2268051C2 (ru) * 2003-12-15 2006-01-20 Закрытое акционерное общество "Фармацевтическое предприятие "Оболенское" Лекарственная форма, обладающая бактериостатическим действием, и способ ее изготовления
TR201009167A2 (tr) * 2010-11-05 2012-05-21 Bi̇lgi̇ç Mahmut Sefalosporin içeren farmasötik granüller.
TR201010860A2 (tr) * 2010-11-05 2012-05-21 Bi̇lgi̇ç Mahmut Sefdinir formulasyonları için üretim yöntemi.

Also Published As

Publication number Publication date
CA2393614A1 (fr) 2002-10-28
CA2433962A1 (fr) 2002-10-28
CA2393614C (fr) 2003-09-30

Similar Documents

Publication Publication Date Title
KR100415897B1 (ko) 생체 이용율이 높은 페노피브레이트 제약학적 조성물
FI79943C (fi) Foerfarande foer framstaellning av en oralt administrerbar farmaceutisk multipelenhetsberedning.
CA1338553C (fr) Granule pharmaceutique renfermant un produit cellulosique
EP2283822A2 (fr) Procédés de séchage par atomisation pour former des dispersions amorphes solides de médicaments et de polymères
PT642785E (pt) Sistemas de hidrogel heterodisperso de libertacao sustida
NO172168B (no) Fremgangsmaate for fremstilling av faste nifedipinpreparater med hoey biotilgjengelighet og med forlenget virkning
EP1291014A1 (fr) Procédé de fabrication d'une préparation pharmaceutique solide contenant une substance médicamenteuse à faible solubilité
EP3981399A1 (fr) Comprimé solide pour voie orale comprenant un inhibiteur de tyrosine kinase de bruton et son procédé de préparation
CA3124534C (fr) Poudre de cellulose, son utilisation et comprime
CZ20011845A3 (cs) Farmaceutické přípravky obsahující cefuroximaxetil
CN103006600B (zh) 一种苯磺酸氨氯地平片剂及其制备方法
CA2433962C (fr) Compositions antibacteriennes de clarithromycine et processus de preparation connexe
DK2665466T3 (en) Solid molecular dispersion of fesoterodine
CN104546667A (zh) 含泊沙康唑的固体分散体及其制备方法
KR100267525B1 (ko) 시타라빈 옥포스페이트 경질 캡슐제
CA2634006C (fr) Compositions pharmaceutiques a liberation prolongee comprenant de la liothyronine ou du sel de sodium de liothronine
EP0371683B1 (fr) Composition à libération contrôlée à base d'acétate de flecainide
US5534551A (en) Aminoguanidine spray drying process
CN111000813B (zh) 孟鲁司特钠咀嚼片及其制备方法
CN110314150A (zh) 一种替米沙坦风味咀嚼片及其制备方法
JPH04327528A (ja) 経口用固形製剤
HK1004887B (en) Controlled release flecainide acetate formulation
EP4445899A1 (fr) Formes posologiques à libération prolongée pour composés à faible solubilité et procédés de préparation de ces formes posologiques à libération prolongée
CN117137876B (zh) 瑞舒伐他汀钙片及其制备方法
CN103479588B (zh) 一种法莫替丁片剂及其制备方法

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20220719